Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Interest & Investment Income: 2011-2022

Historic Interest & Investment Income for Abeona Therapeutics (ABEO) over the last 10 years, with Jun 2022 value amounting to $30,000.

  • Abeona Therapeutics' Interest & Investment Income rose 275.00% to $30,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $77,000, marking a year-over-year decrease of 80.80%. This contributed to the annual value of $69,000 for FY2021, which is 94.70% down from last year.
  • Abeona Therapeutics' Interest & Investment Income amounted to $30,000 in Q2 2022, which was up 2,900.00% from $1,000 recorded in Q1 2022.
  • In the past 5 years, Abeona Therapeutics' Interest & Investment Income ranged from a high of $652,000 in Q1 2020 and a low of $1,000 during Q1 2022.
  • Moreover, its 3-year median value for Interest & Investment Income was $33,000 (2021), whereas its average is $140,100.
  • Per our database at Business Quant, Abeona Therapeutics' Interest & Investment Income spiked by 2,280.95% in 2018 and then tumbled by 97.70% in 2021.
  • Abeona Therapeutics' Interest & Investment Income (Quarterly) stood at $533,000 in 2018, then plummeted by 83.60% to $52,000 in 2019, then spiked by 421.15% to $40,000 in 2020, then dropped by 10.00% to $36,000 in 2021, then soared by 275.00% to $30,000 in 2022.
  • Its Interest & Investment Income was $30,000 in Q2 2022, compared to $1,000 in Q1 2022 and $36,000 in Q4 2021.